February 17, 2026

Ascentage Pharma Group (AAPG) Stock Analysis: Biotech Giant with 91.92% Potential Upside

Ascentage Pharma Group International (AAPG) has been capturing the attention of investors with its promising pipeline and robust potential upside of 91.92%. Operating in the biotechnology..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Potential 100% Upside Amidst Challenging Financials

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) operates at the cutting edge of biotechnology, merging biology and chemistry with advanced data science and engineering to revolutionize drug discovery...

Centessa Pharmaceuticals plc (CNTA) Investor Outlook: Analyzing a 60% Upside Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) stands as a compelling opportunity within the biotechnology sector, appealing to investors with its strong potential upside of 60.32%. Despite its..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 11.25% Upside Potential

Investors with an eye on the biotechnology sector may find Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) an intriguing prospect. With a robust market capitalization of $6.17 billion..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 52.95% Potential Upside in the Biotech Space

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, stands out with a robust market cap of $1.82 billion. As a commercial-stage biopharmaceutical company,..

Belite Bio, Inc (BLTE) Stock Report: Analyst Ratings Signal Strong Buy with 9.62% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE), a dynamic player in the biotechnology sector, has captured the attention of investors with its promising clinical-stage drug development efforts focused..

Certara, Inc. (CERT) Stock Analysis: Exploring an 86.93% Potential Upside in Healthcare Tech

For investors with an eye on the healthcare technology sector, Certara, Inc. (NASDAQ: CERT) presents an intriguing proposition. With a current market cap of $1.05 billion,..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: 42% Upside Potential Ignites Investor Interest

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is capturing the attention of investors with its promising growth prospects and a compelling potential upside. As a prominent player in..

Apellis Pharmaceuticals (APLS) Stock Analysis: 56% Potential Upside Beckons Investors

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a noteworthy player in the biotechnology sector, with a focus on developing and commercializing innovative therapeutic compounds. Headquartered in Waltham,..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenging Waters in the Healthcare Sector

BGM Group Ltd. (BGM), a player in the healthcare sector specializing in active pharmaceutical ingredients (APIs) and traditional Chinese medicine derivatives, has recently caught the attention..

Investor Outlook: Galapagos NV (GLPG) Faces Challenges Amidst Potential Downside

Galapagos NV (NASDAQ: GLPG), a biotechnology firm hailing from Belgium, is capturing investor attention not only for its innovative medical advancements but also for the financial..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Evaluating a 219.73% Potential Upside in Biotech Innovation

Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotech sector, thanks to its robust pipeline of innovative drug candidates and an impressive potential..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 83% Upside Potential Awaits in Revolutionary Medical Devices

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector with its innovative approach to urologic surgery. Specializing in surgical robotics, this San Jose-based..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Revenue Growth Soars as Analysts Eye 24.65% Upside

Alignment Healthcare, Inc. (ALHC), a key player in the healthcare plans industry, has been capturing investor attention with its remarkable revenue growth and a promising potential..

Premier, Inc. (PINC) Investor Outlook: Navigating A Challenging Healthcare Landscape with a Strong Dividend Yield

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare improvement sector, offers a diverse array of solutions aimed at enhancing provider performance, optimizing supply chains,..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring an 88.57% Upside Potential

GeneDx Holdings Corp. (NASDAQ: WGS) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of..

Scholar Rock Holding Corp. (SRRK) Stock Analysis: Biotech Innovator with Strong Buy Signals

Scholar Rock Holding Corporation (NASDAQ: SRRK) is a notable player in the biotechnology sector, engaging in pioneering work to develop treatments targeting serious diseases influenced by..

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a 21% Upside Potential

Warby Parker Inc. (NYSE: WRBY) stands out in the healthcare sector with its innovative approach to eyewear retail. As a prominent player in the medical instruments..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 32% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) is a standout player in the dynamic biotechnology sector, offering a diverse portfolio of licensed biopharmaceutical assets. Based in Jupiter, Florida,..

Clover Health Investments, Corp (CLOV) Stock Analysis: Exploring a 60% Potential Upside in the Healthcare Sector

Clover Health Investments, Corp (NASDAQ: CLOV) has been catching the attention of investors with its promising 60.07% potential upside, according to recent analyst ratings. Specializing in..

Search

Funds

February 17, 2026

Search

Funds

February 17, 2026

FTSE 100

Funds